NCT00005634 2013-06-19Suberoylanilide Hydroxamic Acid in Treating Patients With Advanced Solid Tumors That Have Not Responded to Previous TherapyMemorial Sloan Kettering Cancer CenterPhase 1 Completed
NCT00045006 2013-05-30Suberoylanilide Hydroxamic Acid in Treating Patients With Advanced CancerNational Cancer Institute (NCI)Phase 1 Completed